SEC 13F Intelligence

Boxer Capital, LLC / VKTX

Boxer Capital, LLC’s Viking Therapeutics Inc Position

Does Boxer Capital, LLC own Viking Therapeutics Inc (VKTX)? Not currently — the last reported position was 300.0K shares worth $25M in Q1 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$25M
Q1 2024
Shares
300.0K
% of Portfolio
+1.21%
Quarters Held
5
position exited

Position History VKTX

Reported value by quarter
Q4 ’22: $14MQ4 ’22Q1 ’23: $33,300Q1 ’23Q2 ’23: $32,420Q2 ’23Q3 ’23: $22MQ3 ’23Q1 ’24: $25MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2024300.0K$25M+1.21%
Q3 20232.00M$22M+1.18%
Q2 20232.00M$32,420+1.50%
Q1 20232.00M$33,300+1.64%
Q4 20221.50M$14M+0.74%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of VKTX.